RESEARCH AND DEVELOPMENT
39 CANCER CONTROL 2021
registries that can provide a continuous stream of highquality data in most countries. This would imply availability
of adequate resources to register all patients with cancer
in a timely fashion, the right to access up-to-date national
or regional death records to establish their vital status, the
legislative stability to operate efficiently over the long term,
and the autonomy to deploy all their data for research. n
I would like to thank Pamela Minicozzi and Veronica Di Carlo for
their help in analysing the questionnaires and preparing the figures.
Professor Claudia Allemani is Professor of Global Public Health
at LSHTM. Her main interests are in international comparisons of
cancer survival, "high-resolution" studies on patterns of care, as
well as the estimation of avoidable premature deaths, with a focus
on their impact on cancer policy. She has 20 years' experience in
this domain. She is co-Principal Investigator of the CONCORD
programme for the global surveillance of cancer survival and
Principal Investigator of VENUSCANCER.
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:
sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136:
2. Ginsburg O, Bray F, Coleman MP, et al. The global burden of women's cancers: a grand
challenge in global health [Lancet Series on Women's Cancers]. Lancet 2017; 389: 847-
3. Coleman MP. Cancer survival: global surveillance will stimulate health policy and
improve equity. Lancet 2014; 383: 564-73.
4. Meara JG, Leather AJM, Hagander L, et al. Global Surgery 2030: evidence and solutions
for achieving health, welfare, and economic development. Lancet 2015; 386: 569-624.
5. International Atomic Energy Agency. Inequity in cancer care: a global perspective. IAEA
Human Health Reports No. 3. Vienna: IAEA, 2011.
6. Atun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet
Oncol 2015; 16: 1153-86.
7. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival
2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients
diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Lancet 2018; 391: 1023-75.
8. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark,
Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership):
an analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.
9. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income
countries. Lancet Oncol 2011; 12: 933-80.
10. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-
2009: analysis of individual data for 25,676,887 patients from 279 population-based
registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010.